Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- Check4 days agoChange DetectedNo text changes were reported for the page; the content remains as published.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 on the page, signaling a newer document version. The change represents an update to the page's revision metadata rather than a substantive content alteration.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedInternal site version updates were applied: revision v3.5.2 was added on 2026-04-09 and 2026-04-13, and revision v3.5.0 was removed on 2026-04-07 and 2026-04-08.SummaryDifference0.1%

- Check32 days agoChange DetectedAdministrative updates added on 2026-04-07 and 2026-04-08 and deletions on 2026-04-01 and 2026-03-31, reflecting page metadata edits.SummaryDifference0.1%

- Check39 days agoChange DetectedMedullary thyroid carcinoma and adrenal cortex carcinoma were added to the list of conditions. Deletions occurred on 2026-03-24 and 2026-03-25.SummaryDifference0.1%

- Check47 days agoChange Detected**Release log update:** Added entries for 2026-03-25 and 2026-03-24 and updated to Revision v3.5.0. Removed entries for 2026-03-17 and 2026-03-14 with the previous Revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.